# Effect of Melatonin on Seizure Outcome, Neuronal Damage and Quality of Life in Patients With Generalized Epilepsy

> **NCT03590197** · PHASE4 · COMPLETED · sponsor: **All India Institute of Medical Sciences, Bhubaneswar** · enrollment: 104 (actual)

## Conditions studied

- Generalized Epilepsy

## Interventions

- **DRUG:** Melatonin 3 mg
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03590197
- **Lead sponsor:** All India Institute of Medical Sciences, Bhubaneswar
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-06
- **Primary completion:** 2020-03-03
- **Final completion:** 2020-04-12
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2020-09-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03590197

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03590197, "Effect of Melatonin on Seizure Outcome, Neuronal Damage and Quality of Life in Patients With Generalized Epilepsy". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03590197. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*